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Abnormal development can lead to deficits in adult
brain function, a trajectory likely underlying adoles-
cent-onset psychiatric conditions such as schizo-
phrenia. Developmental manipulations yielding adult
deficits in rodents provide an opportunity to explore
mechanisms involved in a delayed emergence of
anomalies driven by developmental alterations.
Here we assessed whether oxidative stress during
presymptomatic stages causes adult anomalies in
rats with a neonatal ventral hippocampal lesion, a
developmental rodentmodel useful for schizophrenia
research. Juvenile and adolescent treatment with the
antioxidant N-acetyl cysteine prevented the reduc-
tion of prefrontal parvalbumin interneuron activity
observed in this model, as well as electrophysiolog-
ical and behavioral deficits relevant to schizophrenia.
Adolescent treatment with the glutathione peroxi-
dase mimic ebselen also reversed behavioral deficits
in this animalmodel. These findings suggest that pre-
symptomatic oxidative stress yields abnormal adult
brain function in a developmentally compromised
brain, and highlight redox modulation as a potential
target for early intervention.
INTRODUCTION
Developmental insults can yield adolescent or adult brains with
heightened vulnerability to deleterious environmental factors,
an interaction likely to play a role in neuropsychiatric disorders
of adolescent onset (O’Donnell, 2011). Despite intense research
efforts, we still do not understand themechanisms that could link
genetic risk and early developmental disturbances with adult
deficits. Among the hypotheses being advanced, oxidative
stress stands out as a strong possible mechanism (CabungcalNeet al., 2013b; Do et al., 2009; O’Donnell, 2012b). This idea is sup-
ported by the observation of various polymorphisms in genes
encoding glutathione (GSH) synthesis conferring risk for schizo-
phrenia (Gysin et al., 2007; Tosic et al., 2006). GSH, the most
abundant endogenous antioxidant, is responsible for maintain-
ing cellular oxidative balance (Do et al., 2009). Decreased GSH
levels have been observed in peripheral tissues, cerebrospinal
fluid, and postmortem brains of schizophrenia patients (Do
et al., 2000; Gawryluk et al., 2011; Yao and Keshavan, 2011),
and the GSH precursor N-acetyl cysteine (NAC) increases pe-
ripheral GSH levels and improves neurophysiological deficits in
patients (Berk et al., 2008; Carmeli et al., 2012; Lavoie et al.,
2008). Furthermore, brain GSH levels assessed with magnetic
resonance spectroscopy are decreased in the prefrontal cortex
(PFC) of patients with schizophrenia (Do et al., 2000). However,
while mounting evidence does suggest a role of oxidative stress
in schizophrenia, the time course and neural substrates of oxida-
tive stress induced by developmental disturbances are not well
understood, and whether oxidative stress is causal to behavioral
deficits remains to be determined.
Several rodent models have been designed to test possible
developmental pathophysiological scenarios inmajor psychiatric
disorders. Mice with GSH deficit or mitochondrial dysfunction,
for example, show schizophrenia-related electrophysiological,
morphological, and behavioral anomalies (Steullet et al., 2010).
As these deficits are reversed with NAC (Cabungcal et al.,
2013a; Otte et al., 2011), GSH is likely critical for proper postnatal
brain maturation. Another example is the latent neuropatholog-
ical alteration induced by maternal immune activation, which
becomes evident when combined with juvenile social isolation
(Giovanoli et al., 2013). A widely used tool to assess develop-
mental trajectories of adult-onset prefrontal cortical deficit is
the neonatal ventral hippocampal lesion (NVHL). This procedure
yields adult animals with PFC-dependent electrophysiological,
neurochemical, and behavioral anomalies related to phenomena
observed in schizophrenia, all of which emerge during adoles-
cence (O’Donnell, 2011; Tseng et al., 2009). Of note, NVHL rats
show altered prefrontal inhibitory interneuron maturation during
adolescence (Tseng et al., 2008), highlighting this as a model ofuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc. 1073
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Figure 1. A NVHL Blocks the Adolescent Increase in PV Interneuron
Labeling in the PFC
(A) Representative micrographs of prefrontal PV staining in juvenile (P21) and
adult (P61) SHAM, NVHL, and NAC-treated NVHL rats. Scale bar is 80 mm.
See Figure S1 for lesion extent.
(B) Bar graphs illustrating PV cell counts using unbiased stereology at P21 (left)
and P61 (right) in all four treatment groups. PV cell count increased between
P21 and P61 in SHAM, but not in NVHL, rats. Juvenile NAC treatment rescued
the progression in PV cell numbers in NVHL rats. ANOVA F(5,36) = 4.7, p =
0.002. Age: F(1,36) = 10.2, p = 0.003, Lesion: F(1,36) = 1.36, p = 0.11, Lesion 3
Age: F(1,36) = 6.7, p = 0.014, Treatment: F(1,36) = 3.9, p = 0.057, Treatment 3
Age: n.s.
(C) Diagram illustrating the time course of NAC treatment and juvenile (P21)
and adult (P61) assessments. In this and all other figures, data are expressed
as mean ±SEM; *p < 0.05.
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Antioxidants and Adult Prefrontal Functiondevelopmentally induced, late-onset alterations in prefrontal
cortical excitation-inhibition balance. The NVHL is therefore
a useful tool to test whether oxidative stress is responsible for
adult deficits in a model that does not directly manipulate GSH
or alter redox status, which is important to determine whether
oxidative stress is a consequence of developmental cortical
deficits. Here, we tested whether antioxidant treatment with
NAC during juvenile and adolescent periods affects maturation
of NVHL rats; the aim was to assess whether restoring redox
balance prevented adult deficits in a developmentally compro-
mised brain.1074 Neuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc.RESULTS
One of the most replicated findings in schizophrenia research is
a reduction of markers associated with cortical inhibitory inter-
neurons (Lewis et al., 2012). Adult NVHL rats exhibit electrophys-
iological anomalies caused by altered cortical interneuron
maturation, characterized by abnormal modulation by dopamine
(Tseng et al., 2008). We tested whether parvalbumin (PV)-posi-
tive interneurons in the PFC, including the dorsal prelimbic and
anterior cingulate cortex (ACC), are altered in NVHL rats using
unbiased stereological counting techniques. Between postnatal
day (P) 21 and P61, the number of PV immunoreactive interneu-
rons (PVIs) increased in sham-operated rats, but not in NVHL rats
(Figures 1A and 1B). In juvenile rats (P21), there was no signifi-
cant difference in PVI counts between NVHL and sham rats,
but adult (P61) NVHL rats showed significantly fewer PVIs in
the PFC compared to sham rats. The PVI reduction was pre-
vented with NAC treatment starting at P5 (i.e., 2 days prior to
the hippocampal lesion) and lasting into adolescence (P50; Fig-
ures 1A–1C), suggesting juvenile oxidative stress induced by the
neonatal lesion impairs PVI maturation. Caspase 3 labeling did
not reveal apoptotic activation in the PFC of NVHL rats (data
not shown), suggesting that reduced PVI immunoreactivity
more likely reflects reduced interneuron activity than cell loss.
To assess oxidative stress, we quantified DNA oxidation with
8-oxo-7, 8-dihydro-20-deoxyguanine (8-oxo-dG) labeling. At
P21, NVHL rats exhibited a massive increase in 8-oxo-dG stain-
ing in the PFC compared to sham rats, in both pyramidal neurons
and interneurons, which was completely prevented by NAC
treatment (Figures 2A and 2B). When NVHL rats reached adult-
hood (P61), they still showed increased 8-oxo-dG, albeit less
than at P21 (Figures 2C and 2D). We also observed an increase
in 3-Nitrotyrosine (3-NT) levels in adult PFC of NVHL rats. 3-NT
indicates nitration of proteins due to oxidative and nitrosative
stress (Radi, 2004), and its increase in NVHL rats was prevented
by NAC treatment during development (Figure 3). Thus, juvenile
NAC treatment decreasedmultiple markers of oxidative stress in
adult NVHL rats to levels comparable to control rats, without
affecting the extent of the lesion (Figure S1 available online). A
possible explanation for the levels of oxidative stress detected
in the adult PFC following an NVHL is the reduced glutamatergic
input from ventral hippocampus during development, as block-
ing NMDA receptors induces oxidative stress in PVI (Behrens
et al., 2007). Our data indicate that impairing hippocampal inputs
to the PFC during a critical developmental period elicits PFC
oxidative stress in juvenile rats, which has deleterious effects
on the adolescent maturation of PVI.
To determine the types of interneurons expressing oxidative
stress in NVHL rats, we colabeled 8-oxo-dG with PV, calbindin
(CB) and calretinin (CR). In addition to pyramidal neurons,
increased 8-oxo-dG staining was observed in PVIs, but not in
CB or CR interneurons (Figure 4). About 50% of PVI were cola-
beled with 8-oxo-dG, indicating oxidative stress is pervasive in
this cell population. A marker of PVI maturation is Wisteria
Floribunda agglutinin (WFA), a lectin that recognizes the peri-
neuronal nets (PNNs) enwrapping mature cortical PVI. The
NVHL lesion reduced WFA staining (Figure 5), suggesting that
PVI in adult PFC of NVHL rats show an immature phenotype.
8-
ox
o-
dG
 in
te
ns
ity
 (a
.u
)
0
1
3
4
5
2
B
0
2
6
8
4
PV
8-
ox
o-
dG
M
ER
G
ED
10
15
A
NVHLSHAM NVHL + NACSHAM + NAC ** **
8-
ox
o-
dG
 v
ox
el
s 
(x
10
-4
) *** **
D
PV
C
8-
ox
o-
dG
M
ER
G
ED
NVHLSHAM NVHL + NACSHAM + NAC
0
1
3
4
5
2
8-
ox
o-
dG
 in
te
ns
ity
 (a
.u
)
*** *
0
2
6
8
4
8-
ox
o-
dG
 v
ox
el
s 
(x
10
-4
)
*** *
JUVENILE (P21)
ADULT (P61)
SHAM, Water
SHAM, NAC
NVHL, Water
NVHL, NAC
Figure 2. Oxidative Stress Shown with
8-oxo-dG in the PFC of NVHL Rats
(A) Representative micrographs showing double
labeling for PV (red) and 8-oxo-dG (green) in the
PFC in the four groups at P21. Scale bar is 10 mm.
(B) Summary of the data showing that an NVHL
causes a massive increase in 8-oxo-dG labeling in
the PFC at P21 that is prevented with juvenile NAC
treatment. Top graph illustrates 8-oxo-dG fluo-
rescence intensity, and the bottom graph quan-
tifies the number of labeled voxels in each group.
ANOVA for 8-oxo-dG intensity: F(3,14) = 13.7, p =
0.00002, Lesion F(1,14) = 18.4, p = 0.008, Treatment
F(1,14) = 9.6, p = 0.008, Lesion3 Treatment F(1,14) =
13.0, p = 0.003.
(C) Representative micrographs showing double
labeling for PV (red) and 8-oxo-dG (green) in the
PFC at P61. Scale bar is 10 mm.
(D) Summary of the data showing that the NVHL
increases 8-oxo-dG in the PFC at P61, which is
prevented with juvenile NAC treatment. ANOVA
for 8-oxo-dG intensity: F(3,18) = 7.8, p = 0.001,
Lesion F(1,18) = 12.5, p = 0.002, Treatment F(1,18) =
0.13, p = n.s., Lesion x Treatment F(1,18) = 10.8,
p = 0.004.
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Antioxidants and Adult Prefrontal FunctionThese extracellular matrix alterations were restored with juvenile
NAC treatment (Figure 5). PVI may be highly exposed to
increased oxidative stress because they make up the majority
of fast-spiking interneurons, and their high energy metabolism
may generate more reactive oxygen species (ROS) than non-
fast spiking neurons. It is possible that juvenile PVI are functional
while exhibiting oxidative stress, with the deleterious effects
of oxidative stress becoming evident upon periadolescent PVI
maturation.
If juvenile oxidative stress is the cause of physiological anom-
alies observed in adult NVHL rats, NAC treatment should rescue
these alterations. We conducted whole-cell recordings from py-
ramidal neurons in adult brain slices containing the medial PFC
of SHAM (n = 12), NVHL (n = 16), and NAC-treated NVHL rats
(n = 14). As previously shown in adult NVHL rats and other rodent
models of schizophrenia (Niwa et al., 2010; Tseng et al., 2008),
the dopamine D2-dependent modulation of excitatory postsyn-
aptic potentials (EPSPs) in layer V pyramidal cells was lost inNeuron 83, 1073–1084, SeNVHL rats (Figures 6A–6C). This loss
is likely due to abnormal maturation of
PFC interneurons, as the normal adult
D2modulation includes a GABA-A recep-
tor component (Tseng and O’Donnell,
2007), but oxidative stress in pyramidal
neurons may also play a role. To deter-
mine whether altered PVI-dependent
PFC synaptic responses are due to
oxidative stress, rats were treated with
NAC during development and then tested
for D2 modulation of PFC physiology.
NAC treatment rescued the D2 modula-
tion of synaptic responses in NVHL rats
(Figures 6A–6C), indicating that juvenileand adolescent oxidative stress in NVHL rats alters function of
local circuits in the adult PFC.
The abnormal dopamine modulation of PFC function in NVHL
rats is also observed in vivo. We performed in vivo intracellular
recordings in 38 pyramidal neurons from adult rats (n = 9
SHAM, n = 5 NVHL, and n = 7 NAC-treated NVHL). Baseline
activity was consistent with what has been previously reported
for PFC pyramidal neurons (Lewis and O’Donnell, 2000) and
was not significantly affected by lesion status or NAC treatment.
All recorded cells exhibited spontaneous transitions between the
resting membrane potential (down state; 76.2 ± 1.1 mV) and
the up state (67.6 ± 0.7 mV). Up states occurred at a frequency
of 0.6 ± 0.1 Hz with a duration of 523.6 ± 24.7 ms. The majority of
cells (n = 21) fired spontaneously at a rate of 2.1 ± 0.7 Hz. As pre-
viously reported (O’Donnell et al., 2002), in vivo intracellular
recordings from anesthetized adult NVHL rats revealed an
abnormal increase in pyramidal cell firing in response to burst
stimulation of the ventral tegmental area (VTA) (Figures 6D andptember 3, 2014 ª2014 Elsevier Inc. 1075
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BA Figure 3. Oxidative Stress in the PFC of
Adult NVHL Rats Shown with 3-NT
(A) Representative micrographs showing triple
labeling for 3-NT (green), WFA (blue), and PV (red)
in the three groups. Scale bar is 100 mm.
(B) Summary of the data showing that an NVHL
causes a significant increase in 3-NT labeling in the
PFC at P61 that is prevented with juvenile NAC
treatment. Top graph illustrates 3-NT fluorescence
intensity in each group. One-way ANOVA for 3-NT
intensity revealed a very significant effect of
treatment (F(2,53) = 85.2, p < 0.0001). Comparisons
between each pairs using Tukey-Kramer also
showed significant differences (p < 0.0001) for
SHAM versus NVHL and NVHL versus NAC.
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Antioxidants and Adult Prefrontal Function6E) compared to sham rats. This abnormal increase in firing was
prevented by juvenile NAC treatment (Figures 6D and 6E). These
data indicate that abnormal dopamine function in the PFC
of NVHL rats depends on oxidative stress during juvenile and
adolescent stages.
Abnormal cortical synaptic function in adult NVHL rats should
yield altered information processing that would be prevented
by NAC treatment if it depended on oxidative stress. We tested
mismatch negativity (MMN) using auditory-evoked potentials in
an oddball paradigm in SHAM (n = 6), NVHL (n = 3), and NAC-
treated NVHL rats (n = 3). MMN has high translational relevance,
as it is attenuated in schizophrenia patients (Javitt et al., 1993)
and in animal models (Ehrlichman et al., 2009). We implanted
EEG electrodes in NVHL, NAC-treated NVHL, and sham rats.
MMN was significantly different among groups, with NAC treat-
ment improving MMN in NVHL rats (Figures 7A and 7B). This
observation is consistent with the effect of NAC on MMN in pa-
tients (Lavoie et al., 2008) and indicates the NVHL model repro-
duces an important disease marker that can be prevented by
juvenile antioxidant treatment. As MMN depends on NMDA re-
ceptor function (Umbricht et al., 2000) and NMDA hypofunction
in PVI is suspected in schizophrenia, it is possible that MMN
improvement with NAC results from restored PVI activity.
To assesswhether juvenile oxidative stress leads to behavioral
deficits, we used a behavioral paradigm tested in both animal
models and schizophrenia patients. Prepulse inhibition of the
acoustic startle response (PPI) is a measure of sensorimotor1076 Neuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc.gating that is reduced in patients (Geyer
and Braff, 1987) and NVHL rats (Lipska
et al., 1995). We tested PPI in adult
sham (n = 11), NAC-treated sham (n =
12), NVHL (n = 9), and NAC-treated
NVHL rats (n = 17). Juvenile NAC
treatment prevented the reduced PPI
observed in untreated NVHL rats (Fig-
ure 8A). In addition to loss of PVI matura-
tion and electrophysiological anomalies,
developmental oxidative stress in juvenile
NVHL rats can cause schizophrenia-rele-
vant adult behavioral deficits.
The beneficial effect of NAC treatment
reported above includes a large postnataltreatment that starts prior to the lesion and stops once rats
become young adults. For these results to have a full transla-
tional value, it is critical to determine whether NAC is efficacious
when started at an age that corresponds to the time when pro-
dromal stages can be identified in humans. In another set of
rats, we administered NAC in the drinking water starting at
P35, an age that in rats is equivalent to early adolescence. We
tested for PPI deficits in adult sham (n = 15), untreated NVHL
(n = 12), and NAC-treated NVHL rats (n = 14). Although there
was only a trend for a deficit in untreated NVHL rats compared
to shams in this group, there was a significant difference be-
tween untreated and treated NVHL (Figure 8B). The data indicate
that GSH precursors such as NAC can still be effective even if
initiated after oxidative stress has begun.
One important caveat of NAC is that it also alters glutamate
levels by virtue of its action on the cysteine-glutamate trans-
porter (Moussawi et al., 2009). To test whether redox modulation
and not glutamate level changes were responsible for NAC
effects in NVHL rats, we assessed the effect of two other antiox-
idants that do not alter glutamate. Ebselen is a glutathione
peroxidase (GPx) mimic (Mu¨ller et al., 1984) that induces GPx
expression (Kil et al., 2007) and enhances GSH levels in neurons,
replenishing GSH depleted by neurotoxic mechanisms (Pawlas
and Malecki, 2007). We tested PPI in adult vehicle-treated
SHAM (n = 10), ebselen-treated SHAM (n = 7), vehicle-treated
NVHL (n = 8), and ebselen-treated NVHL rats (n = 9). Ebselen
treatment during adolescence reversed PPI deficits in NVHL
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Figure 4. The NVHL Causes Increased Oxidative Stress in PV, but Not CR and CB Interneurons, which Is Prevented by Developmental NAC
Treatment
(A)Micrographs showing 8-oxo-dG labeling (green) of PV-, CR- andCB-positive interneurons (red) in the PFC of SHAM, NVHL, and NAC-treated NVHL rats. Scale
bar is 10 mm.
(B) Summary of the data. In PV interneurons, 8-oxo-dG labeling increased following anNVHL lesion, whichwas preventedwith NAC treatment (Treatment: F(2,65) =
212.97, p < 0.0001). ***p < 0.001.
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Antioxidants and Adult Prefrontal Functionrats (Figure 8C). In another group of rats, we assessed the effects
of the NADPH oxidase inhibitor and antioxidant apocynin, in
this case delivered through juvenile and adolescent stages.
We tested PPI in adult vehicle-treated SHAM (n = 10), apocy-
nin-treated SHAM (n = 11), vehicle treated NHVL (n = 7), and
apocynin-treated NVHL (n = 5). We again observed a reversal
of PPI deficits (Figure 8D). The data indicate that elevation of
GSH and not glutamate during adolescence rescues PPI deficits
in NVHL rats.
DISCUSSION
We observed increased level of oxidative stress immunolabeling
in the PFC of juvenile NVHL rats, along with a decrease in PV cell
counts, PPI deficit, altered dopamine modulation of local PFC
circuits, and deficits in evoked-related potentials in the EEG of
adult NVHL rats. All these deficits were prevented with NAC
treatment from P5 to P50. PPI deficits were also prevented if
NAC treatment was initiated during adolescence (P35) and by
two other redox modulators. Our data suggest that oxidative
stress in PFC is a core feature mediating alterations induced
by the NVHL, and antioxidant treatment prevents these alter-Neations. Presymptomatic oxidative stress, highly present in PVI
and also observed in pyramidal neurons, is therefore responsible
for diverse schizophrenia-relevant phenomena in a neurodeve-
lopmental model that does not entail a direct manipulation of
redox pathways.
Oxidative stress can affect PFC function via several mecha-
nisms. With high levels of oxidative stress, cell damage or death
can occur via membrane lipid peroxidation, DNA mutagenesis,
alterations in chromatin structure, inactivation of critical en-
zymes, or activation of kinase and caspase cascades (Bitani-
hirwe and Woo, 2011). Redox imbalance can also lead to brain
development disturbances by affecting redox-sensitive cysteine
residues at the DNA-binding sites of transcription factors (Had-
dad, 2002) and affecting mitochondrial DNA, highly susceptible
to oxidation (Jones and Go, 2010). Furthermore, many synaptic
proteins include regulatory redox sites; for example, NMDA re-
ceptors become hypofunctional following oxidation (Steullet
et al., 2006). We detected oxidative stress and nitrosative stress
in PFC pyramidal neurons and PVI in juvenile rats with a NVHL
prior to the onset of electrophysiological and behavioral deficits.
This indicates PVI may still be somewhat functional and that
upon their periadolescent maturation, the deleterious effect ofuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc. 1077
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A B Figure 5. PNNs Are Reduced in the PFC of
Adult NVHL Rats but Rescued by Juvenile
NAC Treatment
(A) Representative micrographs showing double
labeling of PV (red) and WFA (green), which labels
PNN. Scale bar is 10 mm.
(B) Plots illustrating PV interneuron (PVI) counts
(top) and the number of cells colabeled with PV
and WFA (bottom). PVI count is reduced following
an NVHL lesion, and this reduction is prevented
with juvenile NAC treatment. (Overall effect:
F(8,16) = 3.8, p = 0.01, PVI count: F(2,11) = 15.3, p <
0.0007). The number of WFA PVI decreases in
NVHL rats compared to controls, and this reduc-
tion is prevented with juvenile NAC treatment
(PNN count: F(2,11) = 28.5, p < 0.0001). **p < 0.01;
***p < 0.001.
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Antioxidants and Adult Prefrontal Functionoxidative stress renders them into a diseased state as revealed
by the reduction in PV and PNN labeling. Our data indicate that
redox alterations in the NVHL model encompass both oxidative
and nitrosative stress, and treatments that increase GSH (NAC
and ebselen) or decrease ROS generation (ebselen and apocy-
nin) prevent adult-onset behavioral deficits. The increases in
3NT levels point to dysregulation of nitric oxide (NO) and arginine
signaling, as well as nitrosative stress, as reported in schizo-
phrenia (Yao et al., 2004). Whether this dysregulation implicates
the various isoforms of NO synthase (nNOS, eNOS, or iNOS) is
still unknown. Thus, the NVHL model presents a widespread
alteration in redox pathways that could be reversed by targeting
different modulators, such as GSH, GPx, and NADPH oxidase.
Oxidative stress is also seen in another animal model of
schizophrenia: the dominant negative DISC1 (DN-DISC1) mouse
(Johnson et al., 2013). Similar to our findings, DN-DISC1 mice
show increased 8-oxo-dG staining in the PFC that is associated
with several behavioral deficits (Johnson et al., 2013). Our results
add to this observation by showing a causal link between height-
ened oxidative stress in the PFC and the electrophysiological
and behavioral deficits associated with schizophrenia, as the
antioxidant NAC prevents both the increase in oxidative stress
and electrophysiological and behavioral deficits in NVHL rats.
PFC physiology was dysfunctional in adult NVHL rats, and this
deficit was prevented by NAC treatment. We used several end-
points to assess PFC function, including dopamine modulation
of synaptic responses in pyramidal neurons in slices, in vivo
intracellular recordings of responses to VTA stimulation, and
auditory-evoked potentials. Recordings from pyramidal neurons
showed loss of D2-mediated attenuation of cortico-cortical
EPSPs in slices and exaggerated firing evoked by VTA stimula-
tion in vivo in adult NVHL rats, as we had reported previously
(O’Donnell et al., 2002; Tseng et al., 2008). Both the slice D2
attenuation of pyramidal cell synaptic responses and the in vivo
silencing of pyramidal neurons by VTA stimulation are depen-1078 Neuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc.dent on activation of FSI by dopamine
in naive rats (Tseng and O’Donnell,
2007). The absence of alterations in
these responses in NAC-treated NVHL
rats indicates that oxidative stress duringpostnatal development has a deleterious effect on dopamine-
modulated FSI-pyramidal cell interactions. Currently, there is a
debate as to whether interneurons or pyramidal neurons are
the primary site of dysfunction in schizophrenia. Our data are
agnostic to which cell type is primarily affected and highlight
oxidative stress as a cause of altered interactions between pyra-
midal neurons and inhibitory interneurons.
Oxidative stress could be brought up in the NVHL model by a
number of mechanisms. First, this could be the result of the
administration of an excitotoxic agent, such as ibotenic acid.
Our previous work showing that neonatal ventral hippocampal
injection of the bacterial endotoxin LPS yielded anomalies similar
to the NVHL (Feleder et al., 2010) suggests this could be the
case. However, a variation of this model in which the hippocam-
pus was just reversibly inactivated produces similar behavioral
alterations as the lesion (Lipska et al., 2002), suggesting the
excitotoxic damage in the NVHL may not be what causes the
deficits. It is more likely that the loss of hippocampal-prefrontal
synaptic activity and/or the loss of trophic factors in the PFC
induced by the loss of hippocampal inputs during a critical devel-
opmental stage may affect the developing prefrontal cortical
neurons. This possibility is supported by work by Margarita Beh-
rens showing that NMDA receptor antagonists can induce oxida-
tive stress in PV interneurons (Behrens et al., 2007, 2008). Thus,
oxidative stress in NVHL rats may be a consequence of network
developmental alterations.
MMN is a measure of high translational relevance. MMN tests
the attribution of saliency to deviant auditory stimuli, and it is dis-
rupted in schizophrenia patients (Javitt et al., 1993). Here,
we report MMN deficits in NVHL rats, which are prevented by
NAC treatment. As MMN is dependent on NMDA receptor activ-
ity (Ehrlichman et al., 2009), it is likely that oxidative stress im-
pairs NMDA-dependent synaptic cortical mechanisms involved
in processing of salient versus common signals. The functional
assessment of the impact of antioxidant treatment was
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Figure 6. Electrophysiological Deficits Are Rescued by NAC Treatment in NVHL Rats
(A) Representative traces of EPSPs evoked by superficial layer electrical stimulation in adult PFC before (black trace) and after (green trace) bath application of the
D2-agonist quinpirole (5 mM).
(B) Neurobiotin-filled layer V pyramidal cell in the PFC; the relative position of the bipolar stimulating electrode and the recording electrode are shown
schematically.
(C) Bar graphs illustrating the magnitude of EPSP attenuation by quinpirole in slices from SHAM, NVHL, and NAC-treated NVHL rats. In sham rats, quinpirole
reduces the size of the synaptic response, whereas in NVHL rats this attenuation is absent. NAC treatment during development reverses this deficit in NVHL
animals (ANOVA: F(2,39) = 3.328, p = 0.046).
(D) Traces from in vivo intracellular recordings in PFC pyramidal neurons showing responses to electrical stimulation of the VTAwith trains of five pulses at 20 Hz in
anesthetized SHAM (top), NVHL (middle), and NAC-treated NVHL (bottom) rats. Each panel is an overlay of five traces that illustrate the representative type of
response observed in each group, with NVHL showing enhanced firing following VTA stimulation, while firing is sparse in SHAM and NAC-treated NVHL rats.
(E) Bar graph illustrating group data for action potential firing in the 500ms epoch following VTA stimulation in all three groups. ANOVA: F(2,37) = 4.5, p < 0.05; NVHL
firing was higher than in shams (post hoc Tukey’s q = 3.9, p < 0.05) and higher than in NAC-treated NVHL rats (post hoc Tukey’s q = 3.6, p < 0.05). In all
electrophysiology experiments data from SHAM and NAC-treated SHAM rats were combined as they did not show differences.
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Antioxidants and Adult Prefrontal Functioncomplemented by testing of sensorimotor integration with PPI.
Both juvenile and adolescent-only NAC treatment prevented
adult PPI deficits in NVHL rats. The observation that adolescent
treatment with NACor ebselen is sufficient to prevent PPI deficits
has important implications for redox mechanisms as potential
targets for schizophrenia treatment. We showed that it is
possible to prevent or reverse a deficit even if antioxidant treat-
ment is initiated after the development of oxidative stress. As
ultra-high-risk subjects for schizophrenia cannot be identified
until adolescence, our finding keeps open the possibility that
redox modulation can be beneficial even if initiated once high
risk has been identified.
Our data reveal that presymptomatic oxidative stress can
cause aberrant adult PFC function in NVHL rats. This develop-
mental manipulation is a well-established model of altered
cortical excitation-inhibition balance. As is the case with any
schizophrenia-related models, the NVHL should not be seen as
reproducing the disease (there is no such thing as a schizo-
phrenic rat). In addition, the model entails a lesion, which is not
observed in schizophrenia. However, the NVHL and other devel-
opmental models have been useful to test specific hypotheses
about developmental trajectories of electrophysiological and
behavioral phenomena of relevance to the disease (O’Donnell,
2013). Major strengths of the NVHL model include the adoles-
cent onset of deficits and the ability to reproduce phenomena
observed in schizophrenia when translatable measures are eval-
uated (O’Donnell, 2012a). Remarkably, the NVHL model con-
verges with several other manipulations used as animal modelsNefor schizophrenia research in producing loss of PVI immunolab-
eling and altered excitation-inhibition balance (O’Donnell, 2011).
Despite their limitations, the behavioral and physiological
endpoints we used here are widely used to assess integrity of
cortical inhibitory networks and their impact on pyramidal cell
activity. Inhibitory networks, developing at the time of the lesion
and beyond, play a crucial role in experience-dependent refine-
ment of neural networks (Hensch, 2005) that extends into
adolescence. This role may be reflected in cognitive training
during adolescence preventing cognitive impairments in adult
NVHL rats (Lee et al., 2012) and adolescent stress unmasking
latent neuropathology in mice with maternal immune activation
(Giovanoli et al., 2013). Adolescence is therefore a critical devel-
opmental stage in which pathophysiological conditions involving
oxidative stress can affect a still developing PFC, but it yet pro-
vides a window of opportunity for therapeutic intervention. This
suggests that antioxidants or redox regulators without serious
side effects may prove effective to reduce conversion in subjects
at risk for psychiatric disorders by preventing pathophysiological
changes associated with loss of cortical pyramidal cell and PVI
function.EXPERIMENTAL PROCEDURES
Animals
Timed-pregnant Sprague-Dawley rats were obtained at gestational days 13–
15 from Charles River (Wilmington) and were individually housed with free ac-
cess to food and water in a temperature- and humidity-controlled environmenturon 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc. 1079
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Figure 7. MMN Deficits Are Rescued by NAC Treatment
(A) Representative traces of auditory-evoked potentials from standard (blue)
and deviant (red) stimuli in a sham (n = 6; top), NVHL (n = 3; middle), and NAC-
treated NVHL rat (n = 3; bottom). The green box highlights the epoch in which
the negativity was measured (35–100 ms following the stimulus). All traces are
averages of at least 80 repetitions.
(B) Group data comparing MMN measured as the area under the curve in the
highlighted region reveal a significant difference among groups (ANOVA:
F(2,11) = 9.742; p = 0.006). The data illustrated are averages from three different
sessions in each rat. A post hoc comparison between NVHL and NVHL+NAC
revealed a significant difference (Bonferroni test; p = 0.005).
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Antioxidants and Adult Prefrontal Functionwith a 12:12 hr light/dark cycle (lights on at 7:00 AM). When pups reached P5,
half of the dams received NAC in their drinking water. Pups were left undis-
turbed until P7–P9, when healthy offspring were randomly separated and
received either NVHL or sham surgery. At P21, male and female pups were
either transcardially perfused with 4% paraformaldehyde for immunocyto-
chemistry or weaned and housed in groups of two to three, counterbalanced
across lesion status. NAC treatment lasted throughout adolescence until P50.
After reaching adulthood (>P60), animals were either perfused with 4%
paraformaldehyde for immunocytochemistry, perfused with artificial cerebro-
spinal fluid (aCSF) for slice electrophysiology, utilized for in vivo intracellular
recordings, or tested for PPI or MMN. All experiments were approved by the
University of Maryland School of Medicine Institutional Animal Care and Use
Committee.
NVHL Surgery
Between P7 and P9, pups (15–20 g) received either an excitotoxic lesion of the
ventral hippocampus (NVHL) or sham procedure, as previously described
(Chambers and Lipska, 2011). Pups were anesthetized with hypothermia
and secured to a Styrofoam platform attached to a stereotaxic frame (David
Kopf Instruments, Tujunga). NVHL rats received a bilateral infusion of ibotenic
acid (10 mg/ml in aCSF, 0.3 ml/side; Tocris, Minneapolis) into the ventral hippo-
campus (3 mm rostral to Bregma, 3.5 mm lateral to midline, and 5 mm from
surface) at a rate of 0.15 ml/min. Sham surgeries were done in exactly the
same fashion, but the guide cannula was lowered only 3 mm and without
any liquid infusion to control for the surgical procedure while avoiding hippo-
campal damage. After the surgery, wounds were clipped, and when pups
activity level had returned to normal, they were returned to their dams and
remained undisturbed until the wound clips were removed and rats weaned
at P21.
In all rats, lesions were verified by sectioning (40 mm) the dorsal and ventral
hippocampus using a freezing microtome. Sections were mounted on glass
slides and Nissl stained. The hippocampus was examined microscopically
for evidence of bilateral damage, which typically included cell loss, thinning,
gliosis, cellular disorganization, and enlarged ventricles (Chambers and
Lipska, 2011).
Antioxidant Pretreatment Regimen
NAC (BioAdvantexPharma, Mississauga) was administered in the drinking wa-
ter at 900 mg/l. NAC treatment started at P5 or at P35, and previous work in
mice has shown that NAC consumed by the dam is transmitted to the pups1080 Neuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc.through her milk (das Neves Duarte et al., 2012). NAC treatment ended at
P50. Fresh solutions were prepared every 2 to 3 days. Ebselen (Sound Phar-
maceuticals Inc., Seattle) was administered intraperitoneally (i.p.) 5 days a
week starting at P35 until the day of PPI testing (P60). Stock ebselen solution
(20 mg/ml DMSO, frozen aliquots) was diluted 1:5 in sterile water and admin-
istered at a dose of 10 mg/kg. Control animals received an equivalent concen-
tration of DMSO diluted 1:5 in water. Apocynin (Sigma-Aldrich, St. Louis) was
administered in the drinking water at a target dose of 100 mg/kg (Nwokocha
et al., 2013). Prior to weaning at P21, drinking water contained a dose of 2 g
apocynin per 0.5 l of water to ensure delivery through the dam’smilk. Apocynin
concentration was lowered after weaning to 750 mg/l to best approximate the
target dose. Treatment lasted from P5 to P50 with fresh solutions prepared
every other day.
Immunohistochemistry
Immunohistochemistry and Stereological Quantification
A total of 18 (P21) and 25 (P61) male rats were anesthetized, perfused, and
their brains fixed as previously described (Cabungcal et al., 2006). Coronal
sections (40 mm) were used to investigate the inhibitory circuitry of ACC. Brain
sections were immunolabeled for PV, as described previously (Steullet et al.,
2010). PV-immunoreactive cell (cell bodies) count was quantified in ACC using
the StereoInvestigator 7.5 software (MBF Bioscience Inc, Williston). Briefly,
stereological counting started with low magnification (32.5 objective) to iden-
tify and delineate the boundaries of the region of interest (ROI) on two to four
consecutive sections from each animal. The ACC (at Bregma approximately
0.70–1.70 mm) was delineated from the secondary motor (M2) cortical regions
following the anatomical cytoarchitectonic areas given by Paxinos andWatson
(1998). The selected ROI included the majority of the cingulate cortex area 1
(cg1) and part of cingulate cortex area 2 (cg2). A small intermediate allowance
was set between ACC and M2 regions to ensure that the ROI in ACC did not
overlap with the secondary motor cortex. A counting box (optical dissector)
within the section thickness and sampling frames adapted to ACC were
used to analyze and count neurons (Schmitz and Hof, 2005). The counting
boxes (40 3 40 mm with 15 mm in depth) were placed by the software in
each sampling frame starting from a random position inside the ROI of the
ACC. Counting was carried out using higher magnification (340 objective).
PV cells were counted when they were in focus at the surface of the box until
out of focus at 15-mm depth of the counting box. A 5-mm guard zone was used
to distance from artifacts that can be influenced by tissue shrinkage due to
the immunopreparation processing. We used 25 counting frames in the ROI
volume of the ACC for P21 and P61 rats.
Immunofluorescence Staining, Confocal Microscopy, and Image
Analysis
Oxidative stress was visualized using an antibody against 8-oxo-7, 8-dihydro-
20-deoxyguanine (8-Oxo-dG), a DNA adduct formed by the reaction ofOH rad-
icals with the DNA guanine base (Kasai, 1997). Because of the proximity of the
electron transport chain, mitochondrial DNA is prone to oxidative damage:
levels of oxidized bases in DNA and levels of 8-oxo-dG are higher in mitochon-
dria than in the nucleus. To assess 8-oxo-dG and 3NT labeling in various types
of interneurons, coronal sections between Bregma 0.70–1.70 mm were incu-
bated for about 36 hr with rabbit polyclonal anti-PV, anti-CB-28k, or anti-CR
(1:2,500; Swant, Bellinzona) primary antibodies togetherwith themousemono-
clonal anti-8-oxo-dG (1:350; AMS Biotechnology, Bioggio-Lugano) primary
antibody or mouse monoclonal anti-nitrotyrosine (1:1,000; Chemicon Interna-
tional, Temecula) primary antibody. To enable visualization of the PNN that
surrounds PV cells, sections were incubated in a solution containing the
biotin-conjugated lectinWFA (Ha¨rtig et al., 1994). Sections were first incubated
with PBS + Triton 0.3% + sodium azide (1 g/l) containing 2% normal horse
serum, followed by 36 hr incubation with rabbit polyclonal anti-PV (1:2,500)
and biotin-conjugated WFA (1:2,000; Sigma). Sections were washed, incu-
bated with appropriate fluorescent secondary antibodies (goat anti-mouse
immunoglobulin G [1:300; Alexa Fluor 488; Molecular Probes, Eugene], anti-
rabbit immunoglobulin G [1:300; CY3; Chemicon International, Temecula],
and CY2-Streptavidin conjugate [1:300; Chemicon]) and counterstained
with 100 ng/ml DAPI (40-6-diamidino-2-phenylindole; Vector Laboratories,
California). Sections were visualized with a Zeiss Confocal Microscope equip-
ped with310,320,340 and363 Plan-NEOFLUAR objectives. All peripherals
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Figure 8. Prepulse Inhibition Deficits Were
Rescued with Antioxidant Treatment
(A) Prepulse inhibition deficits were observed
in NVHL rats when challenged with apomorphine
(0.1 mg/kg, i.p.). This deficit was completely
reversed with juvenile NAC treatment (Lesion:
F(1,42) = 3.529 p = 0.067, Treatment: F(1,42) = 1.644,
p = 0.207, Lesion 3 Treatment: F(1,42) = 5.730, p =
0.021). n = 12–16, *p < 0.05 compared to NVHL.
(B) In another group of rats, NACwas administered
starting at P35, stopped at P50, and the rats tested
for PPI at P61. The bar graph illustrates PPI at
three different prepulse intensities in this group
with adolescent NAC treatment. ANOVA: group
effect F(2,28) = 3.364, p < 0.045; post hoc tests
revealed only a trend for a difference in PPI in
NVHL compared to SHAM (LSD, p = 0.069) and
a significant difference between NVHL and NAC-
treated NVHL (LSD, p = 0.016).
(C) Some animals received ebselen from P35 and
were tested for PPI at P61. There was a significant
lesion effect (F(1,28) = 7.11; p = 0.013) and a sig-
nificant lesion status by treatment interaction
(F(1,28) = 7.09; p = 0.013).
(D) Another set of animals received apocynin
and were tested for PPI. We observed a signifi-
cant lesion by treatment interaction (F(1,25) = 4.8;
p = 0.038).
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Antioxidants and Adult Prefrontal Functionwerecontrolledwith LSM510software (Carl Zeiss AG,Switzerland). Z stacks of
nine images (with a 2.13 mm interval) were scanned (1024 3 1024 pixels) for
analysis in IMARIS 7.3 software (Bitplane AG, Switzerland). All images of Z
stackswere filteredwith aGaussian filter tool to remove unwanted background
noise and sharpen cell body contours. An ROI as defined in the stereological
procedure was created in ACC. The ROI was masked throughout the Z stacks
to isolate regional subvolumes of the ACC in which PV-, CB-, and CR-express-
ing interneurons were analyzed. To quantify 8-oxo-dG, the staining intensity
and number of labeled voxels within the ROI were measured. To quantify 8-
oxo-dG in PV, CB and CR cells, we used theColocmodule of the IMARIS soft-
ware to calculate the proportion of all PV-immunolabeled voxels (respectively,
CB- and CR-immunolabeled voxels), which were also 8-oxo-dG immnola-
beled.Coloc gives the count of colocalized voxels between the immunolabeled
profiles of interest. To quantify the number of PV immunoreactive neurons
surrounded by PNN, we used the spots module to assign spot markings on
profile-labeled voxels that fall within a given size. The channels for PV and
WFA immunolabeling were chosen, and profile size criterion (>9 and 4 mm,
respectively) was defined to quantify labeled profiles above these sizes. Spots
generated for PV that contacted and/or overlapped with spots generated for
WFA were considered as those PVI surrounded by PNN (WFA-positive PVI).
Slice Electrophysiology
Starting at P60, male rats were anesthetized with chloral hydrate (400 mg/kg,
i.p.) 15 min before being decapitated. Brains were quickly removed from the
skull into ice-cold artificial CSF (aSCF) oxygenated with 95% O2-5% CO2
and containing the following (in mM): 125 NaCl, 25 NaHCO3, 10 glucose,
3.5 KCl, 1.25 NaH2PO4, 0.1 CaCl2, and 3 MgCl2 (pH 7.45) (295–300 mOsm).
Coronal slices (300 mm thick) containing the medial PFC were obtained with
a vibratome in ice-cold aCSF and incubated in warm (35C) aCSF solution
constantly oxygenated with 95% O2-5% CO2 for at least 45 min before
recording. The recording aCSF (with 2 CaCl2 and 1 MgCl2) was delivered to
the recording chamber with a pump at the rate of 2 ml/min.Neuron 83, 1073–1084, SePatch electrodes (7–10 MU) were obtained from
1.5 mm borosilicate glass capillaries (World Preci-
sion Instruments) with a Flaming-Brown horizontalpuller (P97; Sutter Instruments) and filled with a solution containing 0.125%
Neurobiotin and the following (in mM): 115 K-gluconate, 10 HEPES, 2
MgCl2, 20 KCl, 2 MgATP, 2 Na2-ATP, and 0.3 GTP (pH 7.25–7.30) (280–285
mOsm). Quinpirole (5 mM, Tocris) was freshly mixed into oxygenated recording
aCSF every day before an experiment. Both control and drug-containing aCSF
were oxygenated continuously throughout the experiments.
All experiments were conducted at 33C–35C and prelimbic or ACC PFC
pyramidal cells from layer V were identified under visual guidance using
infrared (IR) differential interference contrast video microscopy with a 403
water-immersion objective (Olympus BX-51WI). The image was detected
with an IR-sensitive CCD camera and displayed on a monitor. Whole-cell cur-
rent-clamp recordings were performed with a computer-controlled amplifier
(Multiclamp 700A; Molecular Devices), digitized (Digidata 1322; Molecular
Devices), and acquired with Axoscope 9 (Molecular Devices) at a sampling
rate of 10 kHz. Electrode potentials were adjusted to zero before recording
without correcting the liquid junction potential. Baseline activity in each neuron
was monitored for 10 min, during which membrane potential and input resis-
tance (measured with the slope of a current-voltage [I/V] plot obtained with
500-ms-duration depolarizing and hyperpolarizing pulses) were measured.
Synaptic responses were tested in pyramidal neurons with electrical stimu-
lation of superficial layers with a bipolar electrode made from a pair of twisted
Teflon-coated Tungsten wires (tips separated by 200 mm) and placed
500 mm lateral to the vertical axis of the apical dendrite of the recorded
neuron. Stimulation pulses (20–400 mA; 0.5 ms) were delivered every 15 s.
The intensity was adjusted to evoke EPSPs with about half of the maximal
amplitude. Throughout the experiment, changes in input resistance were
monitored with repeated hyperpolarizing steps, and the cell was discarded
when input resistance changedmore than 20%during the course of the exper-
iment. The amplitude of evoked EPSPs was measured with Clampfit 9.0
and averaged over ten sweeps before and after 7 min of application of quin-
pirole. This period was chosen for consistency, with differences revealed by
previous investigations of D2 modulation of PFC activity in rodent models ofptember 3, 2014 ª2014 Elsevier Inc. 1081
Neuron
Antioxidants and Adult Prefrontal Functionschizophrenia (Niwa et al., 2010; Tseng et al., 2008). At the end of each exper-
iment, slices were placed in 4% paraformaldehyde and processed for DAB
staining using standard histochemical techniques to verify morphology and
location of the neurons.
In Vivo Intracellular Recordings
Female rats were anesthetized with choral hydrate (400 mg/kg, i.p) and placed
on a stereotaxic apparatus (Kopf Instruments). Anesthesia was maintained
through recording procedures with continuous choral hydrate (24–30 mg/kg/
hr) via an intraperitoneal catheter. Body temperature was maintained at
approximately 37C using a thermal probe-controlled heat pad (Fine Science
Tools). Concentric bipolar stimulating electrodes (0.5 mm diameter, 0.5 mm
pole separation; Rhodes Medical Instruments Inc.) were lowered into the
VTA (5.8 mm caudal to bregma; 0.5–0.8 mm lateral to midline; 7 to 8 mm
from surface) for stimulation. Recording sharp microelectrodes were pulled
from borosilicate glass (1mmO.D.; World Precision Instruments) on a horizon-
tal Flaming-Brown puller (Sutter Instruments). Sharp electrodes (50–110 MU)
were filled with 2% Neurobiotin (Vector Laboratories) in 2 M potassium ace-
tate. Microelectrodes were lowered into the medial PFC using a hydraulic
manipulator (Trent Wells, Coulterville). Recordings were made in current
clamp, and signals were acquired using a Neurodata Amplifier (Cygnus) and
digitized at 10 kHz using a Digidata A/D converter (Molecular Devices) and
Axoscope 9 software (Molecular Devices) for offline analyses.
Microelectrodes were advanced through the medial PFC until a neuron was
impaled. Neurons included in this study had a resting membrane potential
more negative than 60 mV and action potentials with amplitudes R40 mV
from threshold. To determine responses to endogenous dopamine, the VTA
was stimulated with trains of five pulses at 20 Hz, delivered every 10 s. Eight
to ten sweeps were used to determine cell firing in response to VTA stimula-
tion. Firing was measured in the 500 ms epoch following the last VTA pulse
in all sweeps and compared among experimental groups. At the end of the
experiment, animals were killed with anesthesia overdose, and their brains
removed for histological verification of lesion status and electrode placement.
MMN
NVHL, NAC-treated NVHL, and sham female rats were implanted with chronic
EEG electrodes under isoflurane anesthesia. Electrodes were constructed
with 2 mm diameter silver disks coated with silver chloride and glued on top
of bregma, a location equivalent to human vertex, and the contacts led to an
Omnetics connector on top of the head. Upon a 4-week recovery, rats were
first habituated to the recording chamber, a 30 3 50 cm plexiglass box en-
closed within a stainless steel box. NNM sessions consisted of exposing the
rat to approximately 2,000 tones at two different frequencies (7 or 9 kHz;
30 ms duration) separated by 400 ms, with 95% of the repetitions at one fre-
quency (standard) and 5% at the other frequency (deviant). Tones were deliv-
ered with a speaker mounted inside the enclosure using a TDT RZ6 system
(Tucker Davis, and were counterbalanced so half of the time the deviant was
either frequency. EEG signals were acquired using a 32-channel Omniplex
system (Plexon Instruments) at 1 kHz sampling rate. For analysis, 300 ms
epochs around the tone were selected, filtered at 1–30 Hz, baseline-corrected
to the 100 ms prior to the stimulus, and averaged separately for standard and
deviant tones. A difference wave was constructed by subtracting the standard
wave from the deviant wave, and MMN was quantified by measuring the area
under the curve in the period between 35 and 100ms after the stimulus. All rats
were exposed to three sessions in three different days, and values were
averaged across sessions for every animal.
Prepulse Inhibition
Starting at P60, both male and female rats were tested for PPI, as described
previously (Feleder et al., 2010). As PPI deficits in NVHL rats are most evident
when rats are challenged with apomorphine (Lipska et al., 1995), we injected
apomorphine (0.1 mg/kg, i.p.) immediately prior to the PPI test session. Rats
were placed in a sound-attenuated startle chamber (San Diego Instruments,
San Diego) with a 70 dB background white noise. After a 5 min adaptation
period, the PPI test was initiated with pseudorandom trials every 15 to 25 s.
Either pulse (120 dB), prepulse (75 dB, 80 dB, or 85 dB), no pulse or prepulse +
pulse were delivered. Trials lasted 23 min and eight to ten repetitions of pulse1082 Neuron 83, 1073–1084, September 3, 2014 ª2014 Elsevier Inc.or prepulse + pulse trials were acquired, while null or prepulse only trials were
repeated five times for each prepulse amplitude. Startle magnitude was
measured using an acceleration-sensitive transducer, and PPI was calculated
as the ratio in startle between prepulse + pulse and pulse alone and is ex-
pressed as percent reduction. The initial trials (all pulse alone) were used for
habituation and not included in the analysis. Trials were excluded from analysis
when the animal was moving in the chamber, and sessions were excluded
from analysis when startle amplitude was low or more than 50% of trials
were excluded for any prepulse + pulse combination. If a PPI session was
discarded, rats were tested again a week later.
Statistics
The mean numbers of PV-immunoreactive cells per tissue volume in the ACC
were compared among treatment groups using one-way ANOVA followed by
post doc Dunnett multiple comparisons. Themean number of PV-cells, PV-cell
intensity, WFA-positive PV and WFA-positive intensity, the overall 8-oxo-dG,
and WFA labeling were compared among groups using multivariate ANOVA
(Wilk’s Lambda) followed by post hoc Dunnett test for multiple comparisons.
Electrophysiology data were compared using a one-way ANOVA with group
as between-subject variable. PPI data were compared using a repeated-mea-
sures two-way ANOVA with lesion status and treatment as between-subject
variables and prepulse intensity as within-subject variable.
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